CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 8-K Event Regulation FD disclosure
- 4 Other acquisition President, COO & CFO acquired 1,069 shares (other)
- 4 Option exercise Director acquired 40,000 shares (option exercise)
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 4 Shares withheld for taxes Chief Executive Officer gave up 491,900 shares (to pay taxes)
- 4 Gift Director gave 300,000 shares (gift)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- DEL AM Other DEL AM
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Option exercise Director acquired 46,000 shares (option exercise)
- 10-Q Report Quarterly Report
- 4 Other acquisition President acquired 1,086 shares (other)
- 4 Open-market buy Director bought 10,000 shares at $2.79 ($27,900)
- 4 Open-market buy President bought 5,500 shares at $2.66 ($14,630)
- 4 Open-market buy President bought 2,509 shares at $2.53 ($6,348)
- 4 Derivatives Options or other derivatives
Page 7 of 50 · 983 filings